Home NDC 81238-0240-2 Maximum Allergy Relief
Product NDC 81238-0240
Requested package NDC 81238-0240-2
11-digit product format 812380240
Labeler code 81238
Product ID 81238-0240_6e3cc529-336b-4c7c-a635-0fdbf5f14967
Type HUMAN OTC DRUG
Nonproprietary name ACETAMINOPHEN, PHENYLEPHRINE HCl
Dosage form TABLET
Route ORAL
Labeler Western First Aid Safety DBA Aramark
Application part341
Marketing category OTC MONOGRAPH FINAL
Marketing start 2021-05-07
Marketing end 0000-00-00
Substance ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE
Active strength 500 mg/1; mg/1
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 81238-0240-1 Maximum Allergy Relief 50 in 1 BOX TABLET 50 1 81238-0240-1 Maximum Allergy Relief 2 in 1 PACKET TABLET 2 1 81238-0240-2 Maximum Allergy Relief 125 in 1 BOX TABLET 125 1 81238-0240-2 Maximum Allergy Relief 2 in 1 PACKET TABLET 2 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 81238-0240 MAXIMUM ALLERGY RELIEF (ACETAMINOPHEN, PHENYLEPHRINE HCL) TABLET [WESTERN FIRST AID SAFETY DBA ARAMARK] 1 Legacy NDC, 4 package rows 20210613_cabd4342-7957-42ad-baa3-1f6c512cdf8c.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 81238-0240-2 81238024002 125 PACKET in 1 BOX (81238-0240-2) > 2 TABLET in 1 PACKET 125 packet 2021-05-07 0000-00-00 No No Current